Bristol-Myers to pay $1.85B in cancer deal with Nektar

Added: 14.02.2018 6:58 | 0 views | 0 comments

Source: magseriesusa.net
Source: magseriesusa.net

Nektar will receive $1 billion in cash upfront and Bristol-Myers will purchase about 8.28 million Nektar shares at $102.60 per share, or an equity stake of just under 5 percent of the company

More in feeds.foxbusiness.com »

Tags: Cancer

Image with code
CommentsComments:
advertising
Contact us